NCT01650558View on ClinicalTrials.gov

Daily Trimethoprim-sulfamethoxazole or Weekly Chloroquine Among Adults on ART in Malawi

NACompletedINTERVENTIONAL
Enrollment

1,499

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions
HIV
Interventions
DRUG

Standard of Care prophylaxis

Daily trimethoprim sulfamethoxazole

DRUG

Chloroquine (CQ) prophylaxis

Discontinue standard of care and start weekly CQ.

Trial Locations (2)

Unknown

Blantyre Malaria Project Research Clinic, Blantyre

Tisungane Clinic, Zomba

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

University of Maryland, Baltimore

OTHER

NCT01650558 - Daily Trimethoprim-sulfamethoxazole or Weekly Chloroquine Among Adults on ART in Malawi | Biotech Hunter | Biotech Hunter